Skip to content Skip to footer

Veterelin Buserelin Receptal 0.004 mg/ml 10 ml #5

$67.66

Veterelin (Buserelin) is a peptide hormone which is chemically analogous to the releasing
hormone (RH) of the luteinising hormone (LH) and follicle stimulating hormone
(FSH) thus a gonadotrophin releasing hormone (GnRH) analogue.
The mode of action of the veterinary medicinal product corresponds to the
physiologic-endocrinological action of the naturally occurring gonadotrophin
releasing hormone.

Description

Buy Veterelin 0.004 mg/ml, solution for injection for cattle, horses, pigs, and rabbits

Description of Veterelin 0.004 mg:

Injectable solution for cattle, pigs, horses and rodents.

A ready-to-use colourless, aqueous injection solution for parenteral administration. Each ml contains 4 μg Buserelin and 10 mg benzyl alcohol, Ph.Eur., as antimicrobial preservative. Buserelin is equivalent to the natural LH/FSH releasing hormone produced in the hypothalamus. It causes simultaneous release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the anterior pituitary.

Packaging: Colourless glass vials of 10 (or 20) ml, with bromobutyl rubber closure and aluminium capsules with Flip-off opening ring in PP of blue colour.
The package contains 5 bottles of 10 ml.

Ingredients:

Active substance: Buserelin 0.004 mg (equivalent to 0.0042 mg Buserelin acetate);
Excipient: Benzyl alcohol 10 mg.

Pharmacologial Properties of Veterelin 0.004 mg/ml 10 ml:

For the treatment of infertility of ovarian origin and improvement of pregnancy rate in cows. For the synchronisation of oestrus in dairy cows and for reducing the calving to conception interval in these cows when used in conjunction with a PGF 2α analogue with luteolytic activity as part of a 10 day fixed time insemination regime. To induce ovulation of a mature follicle and thereby to synchronise ovulation more closely with mating in mares. To induce ovulation in pigs (gilts) after oestrus synchronisation in order to facilitate a single fixed time artificial insemination program. For the improvement of conception rate and induction of ovulation in rabbits. To facilitate stripping and reduce mortality due to egg binding in rainbow trout.

Pharmacodynamic Properties of Veterelin 0.004 mg/ml 10 ml:

Buserelin is a peptide hormone which is chemically analogous to the releasing hormone (RH) of the luteinising hormone (LH) and follicle stimulating hormone (FSH) thus a gonadotrophin releasing hormone (GnRH) analogue.
The mode of action of the veterinary medicinal product corresponds to the physiologic-endocrinological action of the naturally occurring gonadotrophin releasing hormone.
GnRH leaves the hypothalamus via the hypophyseal portal vessels and enters the anterior lobe of the hypophysis. Here it induces the secretion of the two gonadotrophins FSH and LH into the peripheral blood stream. These can act physiologically to cause maturation of ovarian follicles, ovulation and lutenization in the ovary.

Pharmacokinetic Properties of Veterelin 0.004 mg/ml 10 ml:

After intravenous administration, Buserelin is degraded rapidly: its half-life is 3 to 4.5 minutes in rat and 12 minutes in guinea pigs. Buserelin is accumulated in the pituitary gland, liver and kidneys where the substance is degraded by enzymes into small peptides fragments with negligible biologic activity. The main excretion route is in the urine.

Indications of Buserelin 0.004 mg 10ml:

FOR COWS (CATTLE)

  • Ovulation induction or delayed ovulation;
  • Treatment of anoestrus;
  • Treatment of follicular cysts with or without symptoms of nymphomania;
  • Improvement of conception rate in artificial insemination procedures, also after synchronisation of oestrus with a PGF2α analogue. Results may however vary depending on breeding conditions;

FOR MARES (HORSES)

  • Ovulation induction and thereby to synchronise ovulation more closely with mating in mares;
  • Treatment of follicular cysts – with or without symptoms of nymphomania;

FOR RABBITS (DOES)
Improvement of conception rate and ovulation induction at post partum insemination.

FOR PIGS (Nulliparous cycling gilts )
Ovulation induction after oestrus synchronization with an analogue of progestagen (altrenogest) in order to perform a single artificial insemination.

Contraindications of Buserelin 0.004 mg 10ml:

Do not use in animals with known hypersensitivity to the active ingredient or to the excipients.

Precautions & Warning of Buserelin 0.004 mg 10ml:

Following withdrawal of the first dose, use the product within 24 hours. Discard unused material. Observe aseptic precautions.
Use of the product contrary to the recommended protocols may result in the formation of follicular cysts which may detrimentally affect fertility and prolificacy.
Avoid eye and skin contact with the solution for injection. In case of accidental contact, rinse thoroughly with water. Should skin contact with the product occur, wash the exposed area immediately with soap and water, as GnRH analogues may be absorbed through the skin.
Pregnant women should not administer the product, as buserelin has been shown to be foetotoxic in laboratory animals.
Women of child-bearing age should administer the product with caution.
When administering the product, care should be taken to avoid accidental self-injection by ensuring that animals are suitably restrained and the application needle is shielded until the moment of injection.
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Wash hands after use.

Side effects:

None.

Interaction with other medicaments:

None known.

Overdose of Buserelin 0.004 mg 10ml:

In the case of repeated administrations of a dose corresponding to 3.5 ml of product, reduced food consumption may be observed in gilts after the 2-nd injection. This effect is transient and no specific treatment is required.

Withdrawal period:

Meat and offal: zero days;
Milk: zero hours.

Storage:

Store below 25°C. Protect from light.

Shelf life:

Shelf life of the veterinary medicinal product as packaged for sale: 24 months;
Shelf life after first opening the immediate packaging: 8 hours.

Consult your veterinarian before using this medication

Dosage:
In cattle, horses and rodents, the intramuscular route is recommended, but it can also be administered intravenously or subcutaneously. Pigs are recommended to be administered intramuscularly, but can also be administered intravenously.

In cattle, horses and rabbits, the preferred route of administration is intramuscular injection (i.m.), but it may also be injected intravenously (i.v.) or subcutaneously (s.c.).

In pigs, the preferred route of administration is intramuscularly (i.m.), but it may also be injected intravenously (i.v.).

Do not pierce the stopper more than 12 times.

When treating large numbers of animals, use a suitable draw-off needle or automatic dosing syringe to avoid excessive puncturing of the closure.

Cattle: For the treatment of cows with fertility disorders of ovarian origin.

Follicular cysts – with or without symptoms of nymphomania – 5.0 ml. In the treatment of follicular cysts in cattle, it is unnecessary to manually express the cysts. A corpus luteum will usually be clearly detectable on either the affected or the normal ovary within about 8 days after administration. At the same time luteinisation and disappearance of the cysts may occur. The response to treatment should be checked after 10-14 days. If no corpus luteum is present, or if newly formed cysts are detected, treatment should be repeated. Artificial insemination or service may take place during the first oestrus after treatment. On average this occurs 20 days after injection.

Acyclia (true anoestrus) – 5.0 ml

To determine that the cow is truly acyclic, two rectal examinations should be carried out with an 11 day interval between examinations. Alternatively, two samples of milk should be taken for milk progesterone assay with an 11 day interval between samples. Oestrus should occur 8-22 days after treatment. If oestrus has not been observed by this stage, a further rectal examination should be carried out. If there are no palpable structures on the ovaries, then treatment should be repeated. If, however, a corpus luteum is palpated, then prostaglandin F2α or one of its analogues should be administered, thus allowing the animal to return to oestrus 2-3 days later.

Delayed ovulation – 2.5 ml.

This condition may be treated at the time of artificial insemination or service, or up to 6-8 hours beforehand. Ovulation is usually induced within 24 hours of treatment.

Improvement of pregnancy rate of cows – 2.5ml The product should be injected at the time of or up to 8 hours before hand. This helps to ensure that ovulation occurs at the correct time after insemination. Improvement of pregnancy rate may also be achieved by a single injection on day 11 or 12 after insemination by helping to prevent luteolysis and consequent embryo mortality.

Note: The induction of ovulation is not possible in the presence of a functional corpus luteum.

Cattle: For the synchronisation of oestrus in dairy cows. The product can be used as part of a 10-day GnRH/prostaglandin/GnRH oestrus synchronisation and insemination regime to increase submission rates and significantly reduce the calving to conception interval. The use of the product 7 days prior to prostaglandin increases the proportion of cows able to respond to the prostaglandin and co-ordinates a new follicular wave so more cows will ovulate during a shorter time after prostaglandin. A second Receptal treatment after the prostaglandin further tightens synchrony of ovulation in relation to the service time. The Intervet GnRH/prostaglandin/GnRH regime (Interceptâ„¢) for breeding dairy cows at a pre-planned time without the need for specific heat detection is summarised below:

Day 0

Veterelin (2.5 ml)

Day 7

Prostaglandin (at luteolytic dose)

Day 9

Veterelin (2.5 ml) 54-56 hours post prostaglandin or at AI if sooner

Day 10

AI 72 hours post prostaglandin or at observed heat if sooner.

When using the Intercept fixed time insemination regime, it is recommended that cows showing signs of oestrus after prostaglandin treatment should be inseminated when observed in oestrus rather than completing the synchronisation programme.

Trials have shown that for cows holding to their first service, use of a GnRH/prostaglandin/GnRH regime can improve the calving to conception interval by 11 days when compared to controls. When including all services, the calving to conception interval was shown to be improved by 7 days.

Horses: For the treatment of mares.

To induce ovulation of a mature follicle and thereby to synchronise ovulation more closely with mating – 10ml.

The product should be administered on the first day on which the follicle has reached its maximum size, this being determined by previous clinical history and rectal examinations. The product is best given approximately 6 hours prior to service. This may be achieved by administering in the morning with service in the afternoon of the same day or alternatively, with the injection given in the early afternoon and service in the evening. The mare should be served again the next morning if she is still in oestrus. If ovulation has not occurred within 24 hours after treatment, then the injection should be repeated.

Pigs (gilts): Induction of ovulation after oestrus synchronisation in order to facilitate a single fixed time artificial insemination programme:10 μg(2.5 ml)/animal. Fixed time insemination should be carried out as follows:

– Administration of Veterelin 115-120 hours after the end of synchronisation treatment with a progestin.

– A single artificial insemination 30-33 hours after Veterelin administration.

Rabbits: Induction of ovulation for post-partum insemination – 0.2 ml.

Administer 0.2 ml subcutaneously, 24 hours after parturition. Insemination should be carried out directly after administration.

Improvement of conception rate – 0.2 ml.

Inject 0.2ml at the time of insemination or mating.

Rainbow trout: To facilitate stripping in male and female fish in spawning condition, and to reduce mortality due to egg binding.

Inject at a dose rate of 0.75-1.0 ml per kg body weight (3‑4 micrograms Buserelin/kg body weight) by intramuscular injection, 2 cm above the lateral line posterior to the dorsal fin. Stripping should be performed 2-3 days after treatment.

PayPal or SEPA or BACS

The choice of metod will be indicated when placing an order, in the user’s personal account.

Shipping:

Delivery tariffs depend on the actual weight and country of destination. In any case, the carrier of delivery from Ukraine, optimal.

Econom Shipping to Worldwide.

In our postal service, as in any other, there is a concept – delivery zones.

There are Three Zones:
1. Austria, Belgium, Gibraltar, Greece, Georgia, Denmark, Jersey, Estonia, Egypt, Israel, Ireland, Iceland, Italy, Cyprus, Latvia, Lithuania, Lebanon, Malta, Morocco, Netherlands, Germany, Norway, United Arab Emirates, Oman, Poland, Portugal, Romania, Saudi Arabia, Serbia, Slovakia, Slovenia, United Kingdom (UK), Turkey, Hungary, Finland, France, Croatia, Switzerland, Sweden.
2. Hong Kong, Canada, China, Korea, United States (USA), Japan.
3. Australia, Aruba, Brazil, Bhutan, Vietnam, Dominican Republic, India, Indonesia, Curacao, Mauritius, Malaysia, Mexico, Myanmar, New Zealand, South Africa, Eswatini, Singapore, Solomon Islands, Thailand, Tuvalu, Chile.

  1. Consult your veterinarian before using this medication.

  2. Before ordering any product, specify the availability. This can be done using e -mail.
  3. If there is no desired product in the list of products, check for the possibility of their purchase. This can be done through e -mail.

Additional information

Weight 250 g
Country/Region of Manufacture

Spain

Manufacturer

LABORATORIOS CALIER,S.A.

Forms of release

Solution for injections

Volume/Weight

5×10 ml

Packing

Cardboard Box, Glass bottle

Reviews

There are no reviews yet.

Be the first to review “Veterelin Buserelin Receptal 0.004 mg/ml 10 ml #5”

Your email address will not be published. Required fields are marked *